{"id":4435,"date":"2018-06-15T15:46:36","date_gmt":"2018-06-15T19:46:36","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4435"},"modified":"2018-06-16T09:57:20","modified_gmt":"2018-06-16T13:57:20","slug":"ipo-weekly-recap-software-tech-ipos-continue-to-shine","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-software-tech-ipos-continue-to-shine\/","title":{"rendered":"IPO Weekly Recap &#8211; Software Tech IPOs continue to shine"},"content":{"rendered":"<p><em><span style=\"font-weight: 400;\">Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the <\/span><b>TRUEST<\/b><span style=\"font-weight: 400;\"> picture of how an IPO is shaping up prior to its debut. We are on <\/span><b>your team. <\/b><span style=\"font-weight: 400;\">Additionally, we provide comprehensive research to outline short and long term risks of the new companies\u2026.. <\/span><b>A full-service firm!<\/b><\/em><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-9.56.23-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4441\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-9.56.23-AM.png\" alt=\"Screen Shot 2018-06-16 at 9.56.23 AM\" width=\"1642\" height=\"223\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-9.56.23-AM.png 1642w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-9.56.23-AM-600x81.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-9.56.23-AM-300x41.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-9.56.23-AM-1024x139.png 1024w\" sizes=\"(max-width: 1642px) 100vw, 1642px\" \/><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/AVLR.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-4372\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/AVLR.jpg\" alt=\"AVLR\" width=\"162\" height=\"35\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Software technology IPOs continued to show impressive syndicate strength as <\/span><b>Avalara, Inc (AVLR) <\/b><span style=\"font-weight: 400;\">debuted with the second highest premium (in terms of dollars against the issue price) of 2018. <\/span><b>AVLR <\/b><span style=\"font-weight: 400;\">priced $1.00 above an already increased range, $24.00, and opened with a first trade of $35.00. That, in fact, turned out to be the low for its opening day as AVLR continued making new highs late in its first session. Avalara traded as high as $44.85 which welcomed investors who sold at top-tick a return of 86.9%.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/VRCA.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-4380\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/VRCA.jpg\" alt=\"VRCA\" width=\"268\" height=\"117\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Puxin.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4376\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Puxin.jpg\" alt=\"Puxin\" width=\"145\" height=\"43\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Two other IPOs that \u2018surprised\u2019 on Friday were <\/span><b>Verrica Pharmaceuticals (VRCA) <\/b><span style=\"font-weight: 400;\">and <\/span><b>Puxin Limited (NEW). <\/b><span style=\"font-weight: 400;\">On the precipice of \u201cbio-week\u201d, VRCA opened 33% above its $15.00 mid-range pricing. VRCA traded with a large spread to start, hitting a high of $22.00 within minutes&#8230;before ultimately settling in around $18.00 for its opening session.<\/span><b> Puxin Limited (NEW) <\/b><span style=\"font-weight: 400;\">priced 7.2mm shares at $17.00 and opened flat but traded extremely well in the first hour &#8212;hitting a high of $22.18 for a gain of 30.4%. <\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/CHRA.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4362\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/CHRA.jpg\" alt=\"CHRA\" width=\"180\" height=\"74\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/USX.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4366\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/USX.jpg\" alt=\"USX\" width=\"378\" height=\"51\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/USX.jpg 378w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/USX-300x40.jpg 300w\" sizes=\"(max-width: 378px) 100vw, 378px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Price sensitivity played a role in two IPOs that came from \u2018less attractive\u2019 sectors this week. <\/span><b>U.S. Xpress Enterprises (USX) <\/b><span style=\"font-weight: 400;\">priced $2.00 below<\/span> <span style=\"font-weight: 400;\">the $18-$20 range and <\/span><b>opened at $16.30 for a 2.1% gain<\/b><span style=\"font-weight: 400;\">. USX did hold its issue price in its first two sessions and hit a high of $16.94 for a gain of 5.9% at top-tick. <\/span><b>Charah Solutions, Inc. (CHRA) <\/b><span style=\"font-weight: 400;\">did not fare as favorably. The company conceded to a $4.00 cut below the $16-$18 range by pricing 7.35mm shares at $12. CHRA opened at $11.75 and traded the majority of the week below issue price. <\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/ADIN.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4356\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/ADIN.jpg\" alt=\"ADIN\" width=\"224\" height=\"76\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">It should be noted that <\/span><b>Adaptive Insights (ADIN)<\/b><span style=\"font-weight: 400;\"> IPO was cancelled on Monday after the company elected to be acquired by Workday Inc (WDAY) for $1.55bn. ADIN would have \u201clikely\u201d been another \u2018hot-deal\u2019 along with AVLR.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As for this week, we are dubbing it \u2018bio week\u2019&#8230;with ten deals on the schedule, eight coming from the biotech sector.<\/span><\/p>\n<p>Please click on the logos below to read a brief preview of each deal.<\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/essential-properties-realty-trust-inc-ipo-preview-eprt\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4433\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EPRT.jpg\" alt=\"Microsoft Word - Essential Properties - Draft S-11 1-22-18.docx\" width=\"268\" height=\"53\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/eidos-therapeutics-inc-ipo-preview-eidx\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4429\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/EIDX.jpg\" alt=\"EIDX\" width=\"196\" height=\"72\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/aptinyx-inc-ipo-preview-aptx\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4425\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/APTX.jpg\" alt=\"APTX\" width=\"223\" height=\"62\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/avrobio-inc-ipo-preview-avro\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4421\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/AVRO.jpg\" alt=\"AVRO\" width=\"181\" height=\"46\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/kezar-life-sciences-inc-ipo-preview-kzr\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4417\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/KZR.jpg\" alt=\"KZR\" width=\"221\" height=\"43\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/i3-verticals-inc-ipo-preview-iiiv\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4413\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/IIIV.jpg\" alt=\"IIIV\" width=\"268\" height=\"188\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/magenta-therapeutics-ipo-preview-mgta\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4409\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/MGTA.jpg\" alt=\"Magenta_logo\" width=\"405\" height=\"113\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/MGTA.jpg 405w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/MGTA-300x84.jpg 300w\" sizes=\"(max-width: 405px) 100vw, 405px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/xeris-pharmaceuticals-ipo-preview-xers\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4405\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/XERS.jpg\" alt=\"XERS\" width=\"230\" height=\"80\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/autolus-therapeutics-ipo-preview-autl\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4401\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/AUTL.jpg\" alt=\"AUTL\" width=\"219\" height=\"51\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/electrocore-ipo-preview-ecor\/\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-4397\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/ECOR.jpg\" alt=\"ECOR\" width=\"191\" height=\"54\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4435","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4435"}],"version-history":[{"count":6,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4435\/revisions"}],"predecessor-version":[{"id":4442,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4435\/revisions\/4442"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}